HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 28 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $29,000 | -68.8% | 46,775 | -16.9% | 0.00% | -73.3% |
| Q2 2019 | $93,000 | -55.3% | 56,285 | -32.4% | 0.02% | -57.1% |
| Q1 2019 | $208,000 | +26.8% | 83,275 | +27.2% | 0.04% | +16.7% |
| Q4 2018 | $164,000 | -51.3% | 65,475 | -1.9% | 0.03% | -48.3% |
| Q3 2018 | $337,000 | +301.2% | 66,775 | +158.2% | 0.06% | +262.5% |
| Q2 2018 | $84,000 | +55.6% | 25,860 | +72.4% | 0.02% | +60.0% |
| Q1 2018 | $54,000 | – | 15,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 2,426,300 | $802,000 | 0.74% |
| Cowen Prime Services LLC | 1,411,500 | $466,000 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 1,205,873 | $398,000 | 0.07% |
| Nantahala Capital Management | 5,113,958 | $1,690,000 | 0.05% |
| HighMark Wealth Management LLC | 80,000 | $26,000 | 0.02% |
| Kalos Management, Inc. | 72,858 | $24,000 | 0.01% |
| Qube Research & Technologies Ltd | 585,187 | $193,000 | 0.00% |
| WINTON GROUP Ltd | 190,146 | $63,000 | 0.00% |
| Ironwood Financial, llc | 1,571 | $1,000 | 0.00% |
| Virtu Financial LLC | 12,049 | $4,000 | 0.00% |